Polomar Health Services Swaps Auditor Amid Going Concern and Legal Turmoil, Dismissing GreenGrowth CPAs for Haskell & White
PMHS sits 80% above its 52-week low of $0.065 on light trading volume (0.2× avg).
Summary
Polomar Health Services dismissed auditor GreenGrowth CPAs and hired Haskell & White LLP. The change comes amid going concern doubts, a major lawsuit, and a terminated merger—raising governance and audit risk flags.
Key Events · Corporate Governance and Compliance · PMHS
-
Auditor Dismissal
GreenGrowth CPAs was dismissed as independent auditor effective July 8, 2026. For fiscal years 2024, 2025, and the interim 2026 period, no disagreements or reportable events were cited.
-
New Auditor Appointed
Haskell & White LLP has been appointed to audit fiscal year 2026 and review Q2 2026 interim financials, subject to client acceptance procedures.
-
Audit Opinion Status
GreenGrowth's prior audit reports for 2024 and 2025 were unqualified; the firm confirms its May 6, 2026 audit opinion remains effective and has not been withdrawn.
-
Distressed Context
The auditor change follows a going concern warning, a $20M lawsuit, a $9.7M IP write-down, and the terminated Altanine merger—heightening the risk of future audit issues.
Analysis · PMHS · Life Sciences
Effective July 8, 2026, Polomar Health Services dismissed its auditor GreenGrowth CPAs and appointed Haskell & White LLP. While the company reports no disagreements or reportable events, the timing is precarious: a going concern warning, a $20 million lawsuit, and a recently collapsed merger already weigh on the firm. Auditor dismissals at distressed companies often hint at deeper issues—fee disputes, scope limitations, or preparation for contentious financial reporting. The new auditor must now navigate written-down IP and significant legal liabilities, raising the risk of a qualified opinion or restatement. This filing compounds existing survival concerns and serves as a red flag.
At the time of this filing, PMHS was trading at $0.12 on OTC in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.07 to $960,000.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.